Insider Transactions in Q2 2023 at Precision Biosciences Inc (DTIL)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 08
2023
|
Dario Scimeca General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
13,361
-16.33%
|
$0
$0.75 P/Share
|
|
Jun 07
2023
|
Shane Barton VP & Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
6,060
+18.06%
|
-
|
|
Jun 07
2023
|
Dario Scimeca General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
31,771
+16.87%
|
-
|
|
Jun 07
2023
|
J. Jefferson Smith Chief Research Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,872
+0.25%
|
-
|
|
Jun 07
2023
|
John Alexander Kelly Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,726
+7.65%
|
-
|
|
Apr 27
2023
|
Alan List Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,771
-12.09%
|
$0
$0.79 P/Share
|
|
Apr 26
2023
|
Alan List Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,027
+28.82%
|
-
|
|
Apr 11
2023
|
Kevin Buehler |
BUY
Exercise of conversion of derivative security
|
Direct |
5,701
+50.0%
|
-
|